FDA Approves Apalutamide for Nonmetastatic Prostate Cancer FDA Approves Apalutamide for Nonmetastatic Prostate Cancer

This is the first approved therapy for prostate cancer patients who have nonmetastatic, castration-resistant prostate cancer.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news